1.Vaiserman, A & Lushchack, O (2017) Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives. J Tranl Med 15, 160.
2.Chang, CI, Huang, KC, Chan, DC, et al. (2015) The impacts of sarcopenia and obesity on physical performance in the elderly. Obes Res Clin Pract 9, 256–265.
3.Witard, OC & Ball, D (2018) The interaction between nutrition and exercise for promoting health and performance. Proc Nutr Soc 77, 1–3.
4.Sakellariou, GK, Lightfoot, AP, Earl, KE, et al. (2017) Redox homeostasis and age-related deficits in neuromuscular integrity and function. J Cachexia Sarcopenia Muscle 8, 881–906.
5.Kwon, YN & Yoon, SS (2017) Sarcopenia: neurological point of view. J Bone Metab 24, 83–89.
6.Liu, W, Klose, A, Forman, S, et al. (2017) Loss of adult skeletal muscle stem cells drives age-related neuromuscular junction degeneration. eLife 6, e26464.
7.Inoue, A, Cheng, XW, Huang, Z, et al. (2017) Exercise restores muscle stem cell mobilization, regenerative capacity and muscle metabolic alterations via adiponectin/AdipoR1 activation in SAMP10 mice. J Cachexia Sarcopenia Muscle 8, 370–385.
8.Tomàs, J, Garcia, N, Lanuza, MA, et al. (2017) Presynaptic membrane receptors modulate ACh release, axonal competition and synapse elimination during neuromuscular junction development. Front Mol Neurosci 10, 132.
9.Ishida, Y, Kiyokawa, Y, Asai, T, et al. (2016) Ameliorating effects of sphingomyelin-based liposomes on sarcopenia in senescence-accelerated mice. Biol Pharm Bull 39, 786–793.
10.Haramizu, S, Ota, N, Otsuka, A, et al. (2014) Dietary milk fat globule membrane improves endurance capacity in mice. Am J Physiol Regul Integr Comp Physiol 307, R1009–R1017.
11.Coto-Montes, A, Boga, JA, Tan, DX, et al. (2016) Melatonin as a potential agent in the treatment of sarcopenia. Int J Mol Sci 17, 1771.
12.Yano, M, Minegishi, Y, Sugita, S, et al. (2017) Milk fat globule membrane supplementation with voluntary running exercise attenuates age-related motor dysfunction by suppressing neuromuscular junction abnormalities in mice. Exp Gerontol 97, 29–37.
13.Haramizu, S, Mori, T, Yano, M, et al. (2014) Habitual exercise plus dietary supplementation with milk fat globule membrane improves muscle function deficits via neuromuscular development in senescence-accelerated mice. Springerplus 3, 339.
14.Kim, H, Suzuki, T, Kim, M, et al. (2015) Effects of exercise and milk fat globule membrane (MFGM) supplementation on body composition, physical function, and hematological parameters in community-dwelling frail Japanese women: a randomized double blind, placebo-controlled, follow-up trial. PLOS ONE 10, e0116256.
15.Ota, N, Soga, S, Hase, T, et al. (2015) Daily consumption of milk fat globule membrane plus habitual exercise improves physical performance in healthy middle-aged adults. Springerplus 4, 120.
16.Ota, N, Soga, S & Shimotoyodome, A (2016) Dietary milk fat globule membrane with semiweekly light exercise improves choice stepping reaction time in healthy Japanese elderly subjects: a randomized double blind, placebo-controlled trial. J Ageing Res Clin Pract 5, 98–101.
17.Minegishi, Y, Ota, N, Soga, S, et al. (2016) Effects of nutritional supplementation with milk fat globule membrane on physical and muscle function in healthy adults aged 60 and over with semiweekly light exercise: a randomized double-blind, placebo-controlled pilot trial. J Nutr Sci Vitaminol (Tokyo) 62, 409–415.
18.Ross, S (2016) Targeting the glycome of the milk fat globule membrane for antiinfective properties. PhD Thesis, National University of Ireland Galway.
19.Cavaletto, M, Giuffrida, MG & Conti, A (2008) Milk fat globule membrane components – a proteomic approach. Adv Exp Med Biol 606, 129–141.
20.Drew, MK & Finch, CF (2016) The relationship between training load and injury, illness and soreness: a systematic and literature review. Sports Med 46, 861–883.
21.Tate, DF, Jackvony, EH & Wing, RR (2003) Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA 289, 1833–1836.
22.Giorgetti, MM, Harris, BA & Jetta, A (1998) Reliability of clinical outcome measures in the elderly. Physiother Res Int 3, 274–283.
23.Lundin, H, Saaf, M, Strender, LE, et al. (2017) Gait speed and one-leg standing time each added to the predictive ability of FRAX. Osteoporos Int 28, 179–187.
24.Moyer, VA, U.S. Preventive Services Task Force (2012) Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157, 197–204.
25.Alvarez, KJ, Kirchner, S, Chu, S, et al. (2015) Falls reduction and exercise training in an assisted living population. J Aging Res 2015, 957598.
26.Pocock, SJ & Stone, GW (2016) The primary outcome fails – what next? NEJM 375, 861–870.
28.Vesper, H, Schmelz, EM, Nikolova-Karashian, MN, et al. (1999) Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129, 1239–1250.
29.Fernando, E, Fraser, M, Hendriksen, J, et al. (2017) Risk factors associated with falls in older adults with dementia: a systematic review. Physiother Can 69, 161–170.